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Perspective
User Fees and Health Care 
Exclusion
In its 2008 annual report, the World 
Health Organization (WHO) urged 
countries to “resist the temptation to 
rely on user fees” [1, p. 26]. Indeed, the 
consensus in the scientific community 
is that user fees have harmful effects on 
health care use and household budgets, 
especially for the poorest [2]. Still, 
as the WHO observes, “…most of the 
world’s health-care systems continue to 
rely on the most inequitable method 
for financing health-care services: out-
of-pocket payments by the sick or their 
families at the point of service” [1, p. 
24].
In Africa, where states lack either the 
will or the capacity to apply tax revenues 
to counter the exclusion caused by user 
fees, there are two broad alternatives 
to user fees at the local level. One 
alternative is to exempt from payment 
those who are permanently excluded 
from health care because they are too 
poor. The other is pre-payment schemes, 
where people are asked to pay before 
they need services. Community-based 
health insurance (CBHI) systems can be 
considered as one of these pre-payment 
modalities. In a randomised controlled 
trial in this issue of PLoS Medicine, Evelyn 
Ansah and colleagues examine the 
effects of free access to service through 
pre-payment schemes [3]. Their study is 
timely, since most international funding 
agencies seem prepared to support 
African states that remove user fees.
What the New Study Adds 
Ansah and colleagues’ study did 
not examine wide-scale national 
experiences of abolishing user fees, as 
happened in countries such as Niger 
and Uganda. Rather, the study was a 
pilot project on free access to a pre-
payment scheme in the Dangme West 
District in southern Ghana. In the trial, 
2,194 households containing 2,592 
Ghanaian children under five years old 
were randomised into a pre-payment 
scheme allowing free primary care, or 
into a control group whose families 
paid user fees for health care (normal 
practice). The study also included an 
observational arm made up of 165 
children whose families had previously 
paid to enrol in the pre-payment 
scheme. The primary outcome was 
moderate anaemia (haemoglobin [Hb] 
< 8 g/dl); secondary outcomes were 
health care utilisation, severe anaemia, 
and mortality. 
Moderate anaemia was detected 
in 37 children (3.1%) in the control 
arm and 36 children (3.2%) in the 
intervention arm (adjusted odds ratio 
1.05, 95% confidence interval [CI] 
0.66–1.67). There were four deaths in 
the control and five in the intervention 
group. Mean Hb concentration, severe 
anaemia, parasite prevalence, and 
anthropometric measurements were 
similar in each group.
This study is important because we still 
lack knowledge about how this type of 
pre-payment scheme could be pro-poor. 
In Rwanda, funding agencies sponsor 
free CBHI coverage for the worst-off, but 
research results are not yet available. In 
fact, it is well known that CBHI [4,5] and 
cost-recovery schemes based on user fees 
[6] are not concerned with the worst-off 
nor with equity. 
The purpose of Ansah and 
colleagues’ study was to verify whether 
free access through pre-payment 
schemes would improve members’ 
health. Thus, what was being tested 
was the effectiveness of pre-payment 
schemes, more than the abolition of 
user fees. But CBHI effectiveness is not 
based just on fees but also on the level 
of trust members have for schemes and 
health workers, as well as the quality of 
care, both of which were at the core of 
the experience. In fact, free access is 
not enough to ensure that services are 
used when needed. 
This study adds new evidence on 
pre-payment. It confirms that user 
fees are only one part of the expenses 
incurred by the sick. Abolishing fees 
is therefore not enough to relieve the 
financial burden, since indirect costs 
can sometimes be oppressive. The study 
also showed that pre-payment schemes 
are not pro-poor, because the worst-off 
are rarely enrolled. The trial found that 
membership in a pre-payment scheme 
leads to greater service utilisation, 
although the effect was only modest. 
Children were taken to primary care 
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Linked Research Article
This Perspective discusses the 
following new study published in PLoS
Medicine:
Ansah EK, Narh-Bana S, Asiamah S, 
Dzordzordzi V, Biantey K, et al. (2009) 
Effect of removing direct payment for 
health care on utilisation and health 
outcomes in Ghanaian children: A 
randomised controlled trial. PLoS Med 
6(1): e1000007. doi:10.1371/journal.
pmed.1000007
Evelyn Ansah and colleagues report 
on whether removing user fees has an 
impact on health care-seeking behavior 
and health outcomes in households with 
children in Ghana.PLoS Medicine  |  www.plosmedicine.org 0013 January 2009  |  Volume 6  |  Issue 1  |  e1000008
facilities significantly more frequently 
in the intervention arm (2.8 episodes 
per person/year) than in the control 
arm (2.5 episodes per person/year), 
but the rate ratio was only 1.12 (95% 
CI, 1.04–1.20). Health care utilisation 
in the intervention group (2.8 episodes 
per person/year) was substantially 
lower than in the observational arm 
that self-enrolled in the pre-payment 
scheme (4.3 episodes per person/
year), giving a rate ratio of 0.56 (95% 
CI, 0.58–0.73). Likewise, enrolment 
encouraged greater utilisation of 
formal primary care only among the 
richest, with no effect on others—
suggesting that pre-payment schemes 
may actually increase inequities.
In sum, this study adds to the current 
evidence on the limits of local health 
insurance systems in Africa, where 
the penetration rate, after more 
than 15 years of promotion by their 
organisations, remains very low (5%).
Methodological Issues in 
Evaluating Pre-Payment Schemes
The main strength of Ansah and 
colleagues’ new study is in the choice 
of an experimental design to assess 
the impact of pre-payment schemes. 
There is, in fact, a considerable gap 
between the enthusiasm generated by 
pre-payment schemes and the scientific 
evidence to support their use. Most of 
the published evaluations are based on 
observational studies that are not very 
robust [4]. We are aware of only three 
studies to date that are based on sound 
experimental designs [7–9]. 
In addition, the authors are to be 
congratulated for having decided to 
assess the intervention’s success on 
the basis of its impacts on health. The 
evaluation of alternative financing 
models is too often based on process 
or output indicators that do not 
tell us much about the real benefits 
to populations. Indeed, it is highly 
questionable to invest important 
resources in promoting alternative 
financing models in low- and middle-
income countries without convincing 
evidence of their effectiveness.
A fundamental rule in programme 
evaluation is that “impact questions 
should ask whether a program achieved 
its ultimate objectives” [5]. A pre-
payment scheme does aim to increase 
utilisation and, ultimately, help restore 
the health of its users. However, these 
are not the only objectives motivating 
promoters and members of such 
schemes. A fundamental function 
of any health insurance system is to 
offer effective financial protection to 
its members, safeguard their assets, 
and help them escape the medical 
poverty trap, i.e., the slide into poverty 
due to costs incurred and income 
lost because of illness [10]. Health 
insurance also contributes to the social 
objective of reducing health care 
inequities, especially those related 
to access to services and the burden 
of illness [11]. Therefore, while it is 
undoubtedly legitimate to assess a pre-
payment scheme by considering its 
impacts on members’ health, judging 
its success solely on such outcomes is 
inappropriate and possibly misleading. 
The main weakness of Ansah and 
colleagues’ study is the way in which 
the authors assessed the success of 
the intervention. Several biases have 
led the authors to judge its success 
on a very limited basis: (1) although 
the scheme benefits all members 
of participating households, the 
study only took into account a sub-
population of beneficiaries (children); 
(2) in this sub-population, only health-
related impacts were considered, and 
among all possible health benefits, only 
the potential gains in malaria-related 
outcomes were considered; and (3) 
among malaria-related outcomes, the 
analysis was restricted solely to one 
indicator: the prevalence of severe and 
moderate anaemia. 
Since the statistical power of the 
study was limited by the low prevalence 
of anaemia among the children 
in the control group (3.1%), and 
the attributable risk for anaemia of 
malaria is not known, this study may 
have been under-powered to detect 
an effect from the intervention. Even 
supposing that the intervention did 
not have the desired effects on malaria-
related outcomes, it is still possible 
that the intervention was associated 
with improvement in other aspects of 
children’s health. Also, the scheme 
might have positively affected the 
health of other groups of enrolees, 
or provided members with effective 
financial protection. And we ultimately 
do not know whether the scheme had 
favourable distributional (equitable) 
impacts across social groups. 
The study’s authors conclude: 
“This lack of any effect, including 
on secondary outcomes such as Hb 
for which the study had good power, 
challenges the assumption that where 
introducing free health care leads to 
changes in utilisation, it can safely 
be assumed to translate into health 
benefits. Given the potential size of 
resources involved in providing free 
health care that could be diverted from 
other priorities on the basis of that 
assumption, this finding is potentially 
important for policymakers.” [3]. But 
given the methodological limitations 
of the study, we believe that the trial 
provides no scientific evidence on 
the effectiveness of the pre-payment 
scheme. It is not correct to conclude, 
as the authors do, that there is a “lack 
of any effect” of the intervention. 
Therefore, we do not think there 
is any support here for questioning 
the opportunity to invest in health 
insurance schemes. We believe that as 
long as there is no evidence that health 
insurance schemes are ineffective, 
protecting families against catastrophic 
health care costs and removing 
financial barriers to health care should 
be a health system priority.
Implications for Research 
In a context of scarce resources, it is 
essential that interventions be chosen 
based on conclusive evidence and 
that outcome evaluations be based on 
robust designs. But the evaluation of 
a complex programme such as a pre-
payment scheme, which has multiple 
objectives and consequences, cannot 
be based on an analysis limited to one 
main outcome. Rather, it requires 
mobilisation of an array of indicators 
that can elucidate this complexity 
and the different causal pathways 
it puts into play [12]. In that case, 
a description of the intervention’s 
theory is indispensable [13]. The 
contribution of qualitative analyses 
[14], or of evaluation designs that 
also take the intervention’s context 
into consideration, should also not 
be overlooked [15,16]. Finally, it is 
imperative that outcome evaluation 
be combined with process evaluation. 
This allows us, particularly, to assess 
any implementation deficits (type III 
evaluation errors) [17].
Equitable Access to Care
Ansah and colleagues’ study and the 
emerging literature on the effects of 
abolishing user fees in Africa [18] show 
that lowering financial barriers could PLoS Medicine  |  www.plosmedicine.org 0014 January 2009  |  Volume 6  |  Issue 1  |  e1000008
promote utilisation of health services, 
as claimed by the WHO Commission 
on the Social Determinants of Health 
[19]. But the decision to abolish fees 
is not enough. People’s trust in their 
health care services must be restored, 
and investments (such as salaries and 
drugs) must be made to improve the 
service offered. While it is clear fees 
must be abolished, how to accomplish 
this is not really known. It is also urgent 
to evaluate processes, unintended 
effects, and the actions of those 
involved in implementation [20,21]. 
Ultimately, the relationship between 
abolishing user fees and current 
health care financing systems in Africa 
must be closely studied. In Ghana, 
the nationwide abolition of fees 
for childbirth services, instituted in 
2005, was stopped in 2008 when the 
state decided to organise a national 
social insurance system. Moreover, 
abolition of fees threatens the (rather 
ineffective) promotion of CBHIs and 
the sustainability of community-based 
financing systems. African public 
health officials and decision makers are 
worried about the relationship between 
abolishing user fees and health care 
financing, and much remains to 
be done to provide them with the 
evidence they require.  
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